Alligator Bioscience AB (publ)
SSE:ATORX.ST
1.178 (SEK) • At close February 20, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) SEK.
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Activities: | ||||||||||
| Net Income
| -248.586 | -192.789 | -141.565 | -144.298 | -214.519 | -153.08 | -62.299 | -56.081 | 203.006 | -77.213 |
| Depreciation & Amortization
| 10.489 | 11.767 | 11.144 | 11.522 | 11.548 | 5.902 | 3.204 | 24.675 | 12.667 | 3.186 |
| Deferred Income Tax
| 26.683 | 0 | -0.236 | 0 | 1.339 | 0 | 0 | 0 | 0 | 0 |
| Stock Based Compensation
| 0.074 | 0.099 | 0.004 | 0.042 | 0.301 | 0.397 | 0.354 | 0 | 0 | 0 |
| Change In Working Capital
| 47.735 | 8.981 | 3.555 | -8.489 | 20.242 | 40.748 | -42.869 | -6.921 | -10.821 | 10.86 |
| Accounts Receivables
| 13.267 | -5.859 | -13.589 | 2.119 | 25.291 | 25.979 | -43.351 | -12.229 | -0.833 | 3.195 |
| Inventory
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Accounts Payables
| 34.468 | 14.84 | 17.144 | -10.608 | -5.049 | 14.769 | 0.482 | 5.308 | -9.988 | 0 |
| Other Working Capital
| 34.468 | 14.84 | 17.144 | -10.608 | -5.049 | 14.769 | 0.482 | 5.308 | -9.988 | 7.665 |
| Other Non Cash Items
| 1.002 | -0.665 | 0.065 | -0.129 | 2.126 | 2.315 | 2.335 | 0.717 | 0.042 | 0.431 |
| Operating Cash Flow
| -189.286 | -172.607 | -127.033 | -141.352 | -178.963 | -104.115 | -99.629 | -37.61 | 204.894 | -62.736 |
| Investing Activities: | ||||||||||
| Investments In Property Plant And Equipment
| -2.459 | -0.44 | -0.045 | -0.102 | -2.185 | -7.665 | -14.2 | -3.596 | -2.025 | -4.026 |
| Acquisitions Net
| 0 | 0 | 0 | 0 | 0 | 0.01 | 0 | 0.045 | 0 | 0 |
| Purchases Of Investments
| -50 | 0 | 0 | 0 | 0 | 0 | -74.52 | 0 | 0 | 0 |
| Sales Maturities Of Investments
| 50 | 0 | 0 | 156.988 | 20 | 0 | 0 | 0.957 | 2.291 | 0 |
| Other Investing Activites
| 0 | 0 | -0.045 | 53.726 | 169.884 | 0.01 | -74.694 | 0.046 | 1.104 | 0.001 |
| Investing Cash Flow
| -2.459 | -0.44 | -0.045 | 156.886 | 17.815 | -7.655 | -88.72 | -2.593 | 0.266 | -4.025 |
| Financing Activities: | ||||||||||
| Debt Repayment
| -9.754 | -7.91 | -0.301 | -0.354 | -7.077 | 0 | 0 | 0 | 0 | 0 |
| Common Stock Issued
| 171.315 | 0.806 | 342.665 | 0 | 0 | 0 | 5.175 | 360.003 | 121.073 | 34.965 |
| Common Stock Repurchased
| 0 | -0.38 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Dividends Paid
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Financing Activities
| -9.754 | 7.567 | -40.569 | -5.794 | 0.779 | 0 | 5.175 | -32.665 | 121.073 | 34.965 |
| Financing Cash Flow
| 161.561 | -7.827 | 301.795 | -6.148 | -6.298 | 0.001 | 5.175 | 327.338 | 121.073 | 34.965 |
| Other Information: | ||||||||||
| Effect Of Forex Changes On Cash
| -1.004 | 0.032 | 0.06 | 0.145 | 1.438 | 1.728 | -3.043 | 6.396 | 1.944 | 0.002 |
| Net Change In Cash
| -31.187 | -180.843 | 174.806 | 9.452 | -166.008 | -110.041 | -186.217 | 293.531 | 328.177 | -31.796 |
| Cash At End Of Period
| 66.118 | 97.305 | 278.148 | 103.342 | 196.87 | 362.878 | 472.919 | 659.136 | 365.605 | 37.428 |